The number of active cases stood at 3,99,436, an increase of 1,336 in a span of 24 hours, and comprises 1.27 per cent of the total infections. The national COVID-19 recovery rate has improved to 97.39 per cent, the data updated at 8 am showed.
The total number of Covid vaccine doses administered so far as part of the nationwide vaccination drive has reached 44.61 crore.
Category:
Pandemic
Latest
India records 43,645 fresh Covid-19 cases, 640 more deaths: Health ministry
Majority in India’s big states with COVID-19 antibodies- survey
India’s coronavirus cases jump by daily record of 97,894
The COVID-19 case fatality rate due to the coronavirus infection was recorded at 1.63 per cent.
There are 10,09,976 active cases of COVID-19 in the country which comprises 19.73 per cent of the total caseload, the data stated.
With 5.12 million cases in all, India is the world’s second-worst affected country, and trails only the United States, which has a caseload of around 6.6 million
Global coronavirus cases to soon surpass 30 million: Reuters tally
The official number of global coronavirus cases is now more than five times the number of severe influenza illnesses recorded annually, according to World Health Organization data.
Around the world, there have been almost 1 million deaths, considered a lagging indicator given the two-week incubation period of the virus. That has well exceeded the upper range of 290,000 to 650,000 annual deaths linked to influenza.
COVID-19 tally in India crosses 50-lakh mark
The COVID-19 case fatality rate due to the coronavirus infection further dropped at 1.63 per cent.
There are 9,95,933 active cases of COVID-19 in the country which comprises 19.84 per cent of the total caseload, the data stated.
According to the ICMR, a cumulative total of 5,94,29,115 samples have been tested up to September 15 with 11,16,842 samples being tested on Tuesday.
Maharashtra: Panel formed to cap charges for CT scans for Covid-19 patients
“Some patients need to undergo CT scans but there have been complaints that private hospitals were charging exorbitantly for such tests. To address these concerns, the government decided to set up a committee,” an official from the state health department said.
Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal
Novavax’s vaccine is currently in mid-stage trials after an early-stage study showed it produced high levels of antibodies against the novel coronavirus. The company plans to begin late-stage trials in the third quarter.Last month, Novavax said it will supply 60 million doses of its coronavirus vaccine candidate to the UK beginning as early as the first quarter of 2021.
Civil aviation recovery to be faster due to market size: Airbus India Prez
“We haven’t reached the pre-Covid situation yet but we are improving. There are several segments that are offering good opportunities. Chartered flights too are offering great support,” IndiGo’s Chief Strategy and Revenue Officer Sanjay Kumar said.
India’s role in production of Covid-19 vaccine critical: Bill Gates
“We’ve been brokering the idea of taking a vaccine and manufacturing it in India, even if it comes from AstraZeneca, Oxford or Novavax or Johnson & Johnson. We’ve publicly talked about the arrangement where a Serum will be able to make very high volume of the AstraZeneca and the Novavax vaccine,” said Gates.
COVID-19 tally in India breaches 48-lakh mark; death toll climbs 79,722
The COVID-19 case fatality rate due to the coronavirus infection has further dropped to 1.64 per cent.
There are 9,86,598 active cases of COVID-19 in the country, while 37,80,107 people have recovered, the data stated.
India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and it went past 40 lakh on September 5.
According to the ICMR, a cumulative total of 5,72,39,428 samples have been tested up to September 13 with 9,78,500 samples being tested on Sunday.
Asia offers more flu shots to head off COVID-19 complications
The moves in Asia echo similar efforts in North America and Europe. In the United States, pharmaceutical firms are expected to provide around 200 million flu vaccines this year, about 20% more than usual.
WHO head urges rich nations to join vaccine scheme by Friday deadline
So far, 92 lower-income nations are seeking assistance via the COVAX facility, part of the WHO’s ACT Accelerator to boost development of vaccines, therapeutics and diagnostics to combat the pandemic. Some 80 higher-income nations have expressed interest, but many must still confirm their intention to join by the end of this week.
“If people in low- and middle-income countries miss out on vaccines, the virus will continue to kill and the economic recovery globally will be delayed,” WHO Director General Tedros Adhanom Ghebreyesus told a WHO regional event for Europe that was broadcast virtually.
“Financial and political investments in preparedness have been insufficient, and we are all paying the price,” said the report by The Global Preparedness Monitoring Board (GPMB).